Logo

AliveCor's KardiaMobile 6L Receives FDA's Clearance as Six-Lead Personal ECG Device

Share this

AliveCor's KardiaMobile 6L Receives FDA's Clearance as Six-Lead Personal ECG Device

Shots:

  • KardiaMobile is the personal ECG device delivering multi-dimensional insight into a patient's heart- connected with the Kardia app used to detect AF- bradycardia- tachycardia- and normal rhythm in an ECG without using gels/wires
  • Kardia 6-lead smartphone ECG tracings can diagnose heart rhythm and conduction abnormalities which are leading indicators of cardiovascular disease and is expected to be available in Jun’19
  • The KardiaMobile six-lead device contains two electrodes on the top of the device & one on the bottom- placing their thumbs on two top electrodes with a bottom electrode is placed on left knee/ankle- forming Einthoven Triangle- providing better insights into electrical activity in the heart

Ref: PRNewsWire | Image: Research Gate

Click here to­ read the full press release 

Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions